1. Aryal, Sajesan, Lu, Rui. . HOXA9 Regulome and Pharmacological Interventions in Leukemia. In Advances in experimental medicine and biology, 1459, 405-430. doi:10.1007/978-3-031-62731-6_18. https://pubmed.ncbi.nlm.nih.gov/39017854/
2. Aryal, Sajesan, Zhang, Yang, Wren, Spencer, Li, Chunliang, Lu, Rui. 2021. Molecular regulators of HOXA9 in acute myeloid leukemia. In The FEBS journal, 290, 321-339. doi:10.1111/febs.16268. https://pubmed.ncbi.nlm.nih.gov/34743404/
3. Tang, Ling, Peng, Lin, Tan, Chao, Chen, Pan, Wang, Hui. 2022. Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential. In Cancer cell international, 22, 349. doi:10.1186/s12935-022-02767-9. https://pubmed.ncbi.nlm.nih.gov/36376832/
4. Wright, Shaela, Zhao, Xujie, Rosikiewicz, Wojciech, Xu, Beisi, Li, Chunliang. 2023. Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens. In Nature communications, 14, 7464. doi:10.1038/s41467-023-43264-5. https://pubmed.ncbi.nlm.nih.gov/38016946/
5. Agrawal-Singh, Shuchi, Bagri, Jaana, Giotopoulos, George, Whetton, Anthony D, Huntly, Brian J P. . HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia. In Blood, 141, 1737-1754. doi:10.1182/blood.2022016528. https://pubmed.ncbi.nlm.nih.gov/36577137/
6. Collins, Cailin T, Hess, Jay L. . Deregulation of the HOXA9/MEIS1 axis in acute leukemia. In Current opinion in hematology, 23, 354-61. doi:10.1097/MOH.0000000000000245. https://pubmed.ncbi.nlm.nih.gov/27258906/
智鼠故事 
